Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	e87-e88
Journal	Journal of Thoracic and Cardiovascular Surgery
Volume	165
Issue number	3
DOIs	https://doi.org/10.1016/j.jtcvs.2020.12.107
State	Published - Mar 2023

ASJC Scopus subject areas

@article{521504dd4341434abd4d9d050fb296ba,

title = "Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?",

author = "Broderick, {Stephen R.}",

year = "2023",

month = mar,

doi = "10.1016/j.jtcvs.2020.12.107",

language = "English (US)",

volume = "165",

pages = "e87--e88",

journal = "Journal of Thoracic and Cardiovascular Surgery",

issn = "0022-5223",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Commentary

T2 - Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?

AU - Broderick, Stephen R.

PY - 2023/3

Y1 - 2023/3

UR - http://www.scopus.com/inward/record.url?scp=85100646486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100646486&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2020.12.107

DO - 10.1016/j.jtcvs.2020.12.107

M3 - Editorial

C2 - 33581899

AN - SCOPUS:85100646486

SN - 0022-5223

VL - 165

SP - e87-e88

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

IS - 3

ER -